Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SiO2 Materials Science has developed and commercialized proprietary hybrid containers with a glass-like barrier using advanced coating technologies. Their products are used in the storage and delivery of sensitive biological drugs and vaccines. The company played a significant role during the COVID‑19 pandemic by supplying vials for vaccine distribution after receiving major U.S. government contracts. They have over 300 patents protecting their core technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SiO2 Materials Science.